SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Acute Sleep Deprivation Leads To Changes In Nighttime Urine Production For Men And Women
August 9, 2007
 · 
1 min read
Lone Star Bio
Study Suggests Estrogen Deficiency Can Lead To Obesity-Induced High Blood Pressure Following Menopause
August 9, 2007
 · 
1 min read
Business
3 Universities Join Cancer Testing Device Trial
August 8, 2007
 · 
1 min read
Lone Star Bio
New Device to Treat Chronic Congestive Heart Failure
August 6, 2007
 · 
1 min read
Drug Development
Cancer Therapy & Research Center (CTRC) Tapped for New Clinical Trial for Lung-Cancer Treatment
July 31, 2007
 · 
1 min read
Lone Star Bio
Breast Cancer Trends: A Marriage Between Clinical Trial Evidence and Epidemiology
July 25, 2007
 · 
1 min read
Lone Star Bio
Protein Protects Anti-Cancer Gene from Chemical Shutdown, University of Texas Study
July 20, 2007
 · 
1 min read
Lone Star Bio
Weight Training can Help with Heart Trouble: American Heart Association
July 17, 2007
 · 
1 min read
Drug Development
Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial, University of Texas M. D. Anderson Cancer Center Study
July 10, 2007
 · 
1 min read
Lone Star Bio
Specific Type of Cell Death May Accelerate Decompensated Heart Failure, UT Southwestern Medical Center Study Shows
July 5, 2007
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis
February 19, 2026
 · 
7 min read
Press Releases
AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
February 19, 2026
 · 
31 min read
Press Releases
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer
February 19, 2026
 · 
5 min read
Press Releases
Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation
February 19, 2026
 · 
3 min read
Press Releases
Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
February 19, 2026
 · 
5 min read
Press Releases
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
February 18, 2026
 · 
4 min read
Press Releases
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 18, 2026
 · 
3 min read
Press Releases
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
February 18, 2026
 · 
10 min read
Press Releases
Medicenna Therapeutics Announces Participation in Upcoming Conferences
February 18, 2026
 · 
4 min read
Press Releases
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026
February 17, 2026
 · 
1 min read
Load More